Stocks
Chimerix IncorporatedCMRX
HealthcareBiotechnology
A biopharmaceutical company focused on developing therapies for orphan and rare diseases, with a pipeline that includes treatments for viral infections and oncology indications. Investors track Chimerix for its clinical trial catalysts and potential regulatory milestones, particularly around its lead drug candidate for a rare form of brain cancer.
Congressional Interest in Chimerix Incorporated (CMRX)
1 member of Congress has disclosed 2 trades in Chimerix Incorporated (CMRX), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
2
Sells
0
Who in Congress Is Trading CMRX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-12-09 | JAMES B. RENACCI | buy | $1K-$15K |
| 2015-01-26 | JAMES B. RENACCI | buy | $15K-$50K |